Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon ‐α treatment in HBeAg‐positive chronic hepatitis B patients
This article is protected by copyright. All rights reserved
Source: Journal of Medical Virology - Category: Virology Authors: Ming ‐Yu Zhu, Pei‐Zhan Chen, Jing Li, De‐Min Yu, Dao Huang, Xue‐Juan Zhu, Yue Han, Jie Chen, Wei Huang, Yong‐Yan Chen, Qi‐Ming Gong, Jie‐Hong Jiang, Dong‐Hua Zhang, Yan Zhang, Ji‐Ming Zhang, Xin‐Xin Zhang Tags: Research Article Source Type: research